About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.Stay Connected
My Profile
I am an authority on regulatory aspects of communications and medical products, with particular emphasis on pre-approval communications; strategist to help pharma and biotech companies prepare best case for advisory committee approval; and counselor in issues and crisis management. I am a frequent speaker on various aspects of same - drug development, promotion, reimbursement and new media in a highly regulated environment. Author of books, newspaper and magazine pieces related to drug marketing and promotion as well as HIV specialty pieces. And of course... blogger!About This Blog
Eye on FDA is published by Mark Senak of FleishmanHillard’s New York office. The thoughts and ideas in this blog and postings are strictly my own and are not screened by my employer. Everything posted on this blog is my personal opinion and does not necessarily represent the views of FleishmanHillard or its clients.
Posts by Date
Twitter List
Legislative Tracking Tools
Monthly Archives: October 2008
FDA Issues Warning Letters to Bayer HealthCare for Marketing Two Unapproved Drugs
Here is a significant movement by FDA and a press release just received: The U.S. Food and Drug Administration today sent Warning Letters to Bayer HealthCare concerning two unlawful, over-the-counter (OTC) aspirin products — Bayer Women’s Low Dose Aspirin + … Continue reading
Posted in FDA Policy, Warning Letters
1 Comment
Weekly Roundup – 10-24-08
As we enter the home stretch of the election cycle, I find myself wanting very badly for it to be November 5. For me, this was once again another very busy week that included preparation for another speaking gig that … Continue reading
Posted in Weekly Roundup
Comments Off on Weekly Roundup – 10-24-08
Bloomberg on Earnings
Here is the latest from Bloomberg Amgen – Lilly
Posted in Finance
Comments Off on Bloomberg on Earnings
Abbott Changes Channels
Perhaps it is a signal that some companies are recognizing the potential of Internet video in general and YouTube in particular that Abbott yesterday took down its Abbott1888 YouTube channel and replaced it with a new AbbottChannel, giving it a … Continue reading
Posted in New and Social Media
Comments Off on Abbott Changes Channels
A Quick Vid on My Thoughts on Video and Pharma
Last week I had the pleasure of speaking at the Second Annual ExL Pharma Digital Healthcare Conference held in Princeton, New Jersey. On my way out, Doug Simon asked if we migh chat for his Vlog on pharma and the … Continue reading
Posted in New and Social Media
Comments Off on A Quick Vid on My Thoughts on Video and Pharma